Lidocaine-01 (4d26041a 97b7 4cb7 B6e0 0b62cd5b23f2 01)
Lidocaine Hydrochloride Solution
Product Images NDC 0116-4025
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 0116-4025). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Xttrium Laboratories, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Lidocaine 4 Ctn (Lido Ctn)
This text appears to be a product label for Topical Anesthetic solution containing Lidocaine Hydrochloride (4%) for oral administration. It provides information on inactive ingredients, dosage instructions, storage conditions, manufacturer details, and warnings regarding keeping the product out of reach of children. The product is intended for topical use only and should not be injected. Proper storage temperature is also provided.*
Lidocaine 4 Pdp (Lido Pdp)
This is a description of Lidocaine Hydrochloride Topical Solution, USP, with a concentration of 1%. It is indicated for topical use only as a local anesthetic for oral administration. Each 1 mL of solution contains 40mg of Lidocaine Hydrochloride Monohydrate, USP. The product is packaged in a 50mL container and should not be used if the seal is broken. In case of overdose, seek professional assistance or contact a Poison Control Center immediately. The product should be stored at 20 to 25 degrees Celsius and freezing should be avoided. The manufacturer is Xtrium Laboratories, Inc. located in Mount Prospect, IL 60056.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
